ProImmune Limited Accelerates Development of Therapeutics with REVEAL(TM) B Cell Epitope Discovery System
3/9/2009 9:56:29 AM
OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd, a leader in epitope discovery and immune monitoring, has launched the REVEAL™ B Cell Epitope Discovery System, a service designed to accelerate the development of biological therapies and understanding of diseases at a structural level. The REVEAL™ service offers both comprehensive best consensus epitope prediction and rapid high throughput linear epitope mapping in vitro.
comments powered by